BeiGene, Ltd. Cash Flow Reinvestment Rate

Latest as of March 2026: 0.20x

BeiGene, Ltd. cash flow reinvestment rate. BeiGene, Ltd. (ONC) has a Cash Flow Reinvestment Rate of 0.20x as of March 2026, reinvesting $40.94 Million (capex $40.91 Million plus investments $27.00K) from operating cash flow of $201.94 Million. Explore how well can BeiGene, Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

$40.94 Million
Capex + Investments

Operating Cash Flow

$201.94 Million
USD

Capital Expenditures

$40.91 Million
USD

Cash Flow Reinvestment Rate of BeiGene, Ltd. (2013–2025)

Cash flow reinvestment rate of BeiGene, Ltd. from 2013 to 2025. Historical reinvestment intensity for BeiGene, Ltd. across 3 annual periods. Explore capital reinvestment ratio of BeiGene, Ltd. to see what proportion of operating cash flow is directed to capital expenditures.

BeiGene, Ltd. Cash Flow Reinvestment Rate by Year (2013–2025)

BeiGene, Ltd. cash flow reinvestment rate by year from 2013 to 2025. Year-by-year capital reinvestment analysis for BeiGene, Ltd.. For the full cash flow conversion analysis, see ONC cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.17x $194.23 Million $1.13 Billion $185.84 Million ▼ -96.3%
2017 4.61x $58.73 Million $12.75 Million $58.73 Million ▲ +7005.2%
2013 0.06x $264.00K $4.07 Million $264.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow